Physician profile
Neha Egbert
NPI 1417204991
$2,607.94
in general payments reported to CMS, 2019-2025
20 companies · $341 in 2025
The $341 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $803 · 2020: $288 · 2021: $296 · 2022: $153 · 2023: $260 · 2024: $466 · 2025: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,068.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,067.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,011.60 | 2019-2023 | Lo Loestrin Fe |
| Daiichi Sankyo INC. | $284.93 | 2023-2025 | Injectafer |
| Biogen, INC. | $266.26 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $167.58 | 2023-2025 | Myfembree |
| Lupin INC. | $156.72 | 2019-2020 | |
| Astellas Pharma US INC | $128.27 | 2023-2025 | Veozah |
| Avion Pharmaceuticals | $120.86 | 2020-2021 | |
| Exeltis, USA INC. | $107.36 | 2022-2025 | Slynd |
| Myovant Sciences INC. | $64.50 | 2021-2022 | |
| Hologic Sales and Service, LLC | $41.49 | 2021-2024 | Aptima |
| Organon LLC | $41.08 | 2023-2024 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $37.65 | 2019-2022 | |
| Agile Therapeutics, INC. | $34.60 | 2021-2022 | |
| Axonics, INC. | $30.16 | 2024 | Bulkamid |
| Pfizer INC. | $27.77 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $23.26 | 2022 | |
| Horizon Therapeutics Plc | $20.71 | 2020 | |
| Glaxosmithkline, LLC. | $15.50 | 2019 | |
| Mylan Pharmaceuticals INC. | $15.08 | 2019 | |
| Mission Pharmacal Company | $12.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neha Egbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.